From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockville, MD 20857.
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004348:Drug Labeling; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006331:Heart Diseases / Q000517:prevention & control; D006801:Humans; D008687:Metformin / Q000627:therapeutic use*; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D008687:Metformin; D001241:Aspirin